Sweden
· Delayed Price · Currency is SEK Vimab Group AB Statistics
Total Valuation
Vimab Group AB has a market cap or net worth of SEK 200.80 million. The enterprise value is 325.59 million.
| Market Cap | 200.80M |
| Enterprise Value | 325.59M |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vimab Group AB has 23.91 million shares outstanding. The number of shares has increased by 10.99% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 23.91M |
| Shares Change (YoY) | +10.99% |
| Shares Change (QoQ) | +0.76% |
| Owned by Insiders (%) | 9.90% |
| Owned by Institutions (%) | n/a |
| Float | 12.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| PB Ratio | 11.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 136.41 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.23 |
| EV / Sales | 1.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65, with a Debt / Equity ratio of 7.71.
| Current Ratio | 0.65 |
| Quick Ratio | 0.35 |
| Debt / Equity | 7.71 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.45 |
Financial Efficiency
Return on equity (ROE) is -162.67% and return on invested capital (ROIC) is -25.87%.
| Return on Equity (ROE) | -162.67% |
| Return on Assets (ROA) | -16.99% |
| Return on Invested Capital (ROIC) | -25.87% |
| Return on Capital Employed (ROCE) | -99.35% |
| Revenue Per Employee | 1.69M |
| Profits Per Employee | -400,734 |
| Employee Count | 192 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 5.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.24% in the last 52 weeks. The beta is -0.70, so Vimab Group AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.70 |
| 52-Week Price Change | -18.24% |
| 50-Day Moving Average | 8.53 |
| 200-Day Moving Average | 9.20 |
| Relative Strength Index (RSI) | 47.76 |
| Average Volume (20 Days) | 12,716 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vimab Group AB had revenue of SEK 325.29 million and -76.94 million in losses. Loss per share was -3.31.
| Revenue | 325.29M |
| Gross Profit | 80.02M |
| Operating Income | -81.87M |
| Pretax Income | -85.58M |
| Net Income | -76.94M |
| EBITDA | -18.68M |
| EBIT | -81.87M |
| Loss Per Share | -3.31 |
Balance Sheet
The company has 12.06 million in cash and 136.84 million in debt, giving a net cash position of -124.79 million or -5.22 per share.
| Cash & Cash Equivalents | 12.06M |
| Total Debt | 136.84M |
| Net Cash | -124.79M |
| Net Cash Per Share | -5.22 |
| Equity (Book Value) | 17.75M |
| Book Value Per Share | 0.74 |
| Working Capital | -63.31M |
Cash Flow
| Operating Cash Flow | 1.47M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 24.60%, with operating and profit margins of -25.17% and -23.65%.
| Gross Margin | 24.60% |
| Operating Margin | -25.17% |
| Pretax Margin | -26.31% |
| Profit Margin | -23.65% |
| EBITDA Margin | -5.74% |
| EBIT Margin | -25.17% |
| FCF Margin | n/a |
Dividends & Yields
Vimab Group AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.99% |
| Shareholder Yield | -10.99% |
| Earnings Yield | -38.32% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vimab Group AB has an Altman Z-Score of -0.74. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.74 |
| Piotroski F-Score | n/a |